| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Y Ishida, H Hashiguchi, R Yamamoto, T Hashitani, T Ikeda, H Nishin. Effect of intra-amygdala dopaminergic grafts on methamphetamine-induced locomotor activity, extracellular dopamine and dopamine metabolite overflow: a comparison with the effect of intra-accumbens grafts. Brain research. vol 549. issue 2. 1991-10-04. PMID:1909206. |
effect of intra-amygdala dopaminergic grafts on methamphetamine-induced locomotor activity, extracellular dopamine and dopamine metabolite overflow: a comparison with the effect of intra-accumbens grafts. |
1991-10-04 |
2023-08-11 |
rat |
| G Pelletier, J Simar. Dopaminergic regulation of pre-proNPY mRNA levels in the rat arcuate nucleus. Neuroscience letters. vol 127. issue 1. 1991-09-30. PMID:1679226. |
in order to study the role of dopamine on neuropeptide y (npy) gene expression in the rat arcuate nucleus, we evaluated the effects of haloperidol, a dopaminergic antagonist, and bromocriptine, a d2 dopamine receptor agonist, on the levels of pre-pronpy mrna as measured by in situ hybridization. |
1991-09-30 |
2023-08-11 |
rat |
| Z S Herman, M Huzarska, K Kmieciak-Kolada, J Kowalsk. Chronic treatment with chlorpromazine, thioridazine or haloperidol increases striatal enkephalins and their release from rat brain. Psychopharmacology. vol 104. issue 1. 1991-09-30. PMID:1881995. |
it is concluded that: 1) chronic administration of neuroleptic drugs that block dopamine receptors increases the level and the release of striatal enkephalins; 2) the results support the hypothesis that activation of dopaminergic neurons tonically inhibits the synthesis of enkephalins in the striatum. |
1991-09-30 |
2023-08-11 |
rat |
| Y Bacq, C Gaudin, A Hadengue, D Roulot, A Braillon, R Moreau, D Lebre. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology (Baltimore, Md.). vol 14. issue 3. 1991-09-26. PMID:1874493. |
systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. |
1991-09-26 |
2023-08-11 |
Not clear |
| Y Bacq, C Gaudin, A Hadengue, D Roulot, A Braillon, R Moreau, D Lebre. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology (Baltimore, Md.). vol 14. issue 3. 1991-09-26. PMID:1874493. |
thus we studied the acute systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine (1.5 micrograms/kg body wt min) in nine cirrhotic patients. |
1991-09-26 |
2023-08-11 |
Not clear |
| Y Bacq, C Gaudin, A Hadengue, D Roulot, A Braillon, R Moreau, D Lebre. Systemic, splanchnic and renal hemodynamic effects of a dopaminergic dose of dopamine in patients with cirrhosis. Hepatology (Baltimore, Md.). vol 14. issue 3. 1991-09-26. PMID:1874493. |
we conclude that a dopaminergic dose of dopamine increases azygos blood flow but not the hepatic venous pressure gradient. |
1991-09-26 |
2023-08-11 |
Not clear |
| O Giorgi, M G Pibiri, E Ongini, M Trampus, G Biggi. The neutral endopeptidase-24.11 (enkephalinase) inhibitor, SCH 32615, increases dopamine metabolism in the nucleus accumbens of the rat. European journal of pharmacology. vol 196. issue 2. 1991-09-20. PMID:1874283. |
the present study was designed to assess whether sch 32615 is able to modify the activity of dopaminergic neurons as reflected by changes in the content of the major dopamine metabolite, dihydroxyphenylacetic acid (dopac), in three different areas of the rat brain: the nucleus accumbens, the striatum, and the prefrontal cortex. |
1991-09-20 |
2023-08-11 |
rat |
| P Aebischer, S R Winn, P A Tresco, C B Jaeger, L A Green. Transplantation of polymer encapsulated neurotransmitter secreting cells: effect of the encapsulation technique. Journal of biomechanical engineering. vol 113. issue 2. 1991-09-20. PMID:1875690. |
in the present study, we compared the ability of dopamine-secreting cells, encapsulated by 2 different methods, to reverse experimental parkinson's disease, a neurodegenerative disease characterized by motor disturbances due to a lack of dopamine within the striatum following degeneration of the dopaminergic nigro-striatal pathway. |
1991-09-20 |
2023-08-11 |
rat |
| J Den. [Effect of dopamine and bromocriptine on secretion of growth hormone by pituitary growth hormone secreting tumor in cell culture]. Zhongguo yi xue ke xue yuan xue bao. Acta Academiae Medicinae Sinicae. vol 12. issue 5. 1991-09-20. PMID:1966332. |
this article reports the effect of dopamine (da) and its agonist bromocriptine (cb154) on the secretion of growth hormone (gh) by pure gh-secreting pituitary tumor in cell culture as well as a comparison of the effects of these dopaminergic drugs and sms201-295 (sms). |
1991-09-20 |
2023-08-11 |
Not clear |
| K M Guthrie, J M Pullara, J F Marshall, M Leo. Olfactory deprivation increases dopamine D2 receptor density in the rat olfactory bulb. Synapse (New York, N.Y.). vol 8. issue 1. 1991-09-16. PMID:1831300. |
we describe here the effects of early olfactory deprivation on other elements of the bulb dopaminergic system, namely the dopamine receptors of the olfactory bulb. |
1991-09-16 |
2023-08-11 |
rat |
| T Huo, D P Heal. [3H]domperidone binding to the kidney inner medullary collecting duct dopamine-2K (DA2K) receptor. The Journal of pharmacology and experimental therapeutics. vol 258. issue 2. 1991-09-11. PMID:1830902. |
dopaminergic drugs were less potent competitors for [3h]domperidone binding in imcd cells than previously reported for brain da receptors, but the rank order was consistent with the labeling of a da receptor [antagonists: domperidone greater than spiperone greater than haloperidol greater than sch 23390 much greater than (-)-sulpiride; agonists: norapomorphine greater than fenoldopam much greater than dopamine = quinpirole], and was better correlated with the pharmacological profile for the brain d2 receptor than the brain d3 receptor. |
1991-09-11 |
2023-08-11 |
Not clear |
| C Fernicola, S Govoni, L Coniglio, E Daniele, M Trabucch. [The use of 1,1,1-trichloroethane (methylchloroform) in industrial operations: the neurotoxicity risk]. La Medicina del lavoro. vol 82. issue 1. 1991-09-11. PMID:1865846. |
it has been also suggested that intermediate metabolites of 1,1,1-te may give origin to condensation products with dopamine, ultimately impairing dopaminergic transmission. |
1991-09-11 |
2023-08-11 |
mouse |
| T Momiyama, M Sasa, S Takaor. Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area. Life sciences. vol 49. issue 7. 1991-09-05. PMID:1677740. |
a microiontophoretic study using rats anesthetized with chloral hydrate and immobilized with gallamine triethiodide was carried out to compare the effect of talipexole (b-ht 920 cl2:2-amino-6-allyl-5,6,7,8-tetrahydro-4h-thiazolo [4,5-d]-azepine-dihydrochloride), a dopamine autoreceptor agonist, on dopaminergic neurons in the ventral tegmental area (vta) to non-dopaminergic neurons in the vta. |
1991-09-05 |
2023-08-11 |
rat |
| T Momiyama, M Sasa, S Takaor. Inhibition by talipexole, a thiazolo-azepine derivative, of dopaminergic neurons in the ventral tegmental area. Life sciences. vol 49. issue 7. 1991-09-05. PMID:1677740. |
these results suggest that talipexole acts on dopamine d-2 receptors, thereby inhibiting the dopaminergic neurons in the vta. |
1991-09-05 |
2023-08-11 |
rat |
| Y Akiyama, K Koshimura, T Ohue, K Lee, S Miwa, S Yamagata, H Kikuch. Effects of hypoxia on the activity of the dopaminergic neuron system in the rat striatum as studied by in vivo brain microdialysis. Journal of neurochemistry. vol 57. issue 3. 1991-09-04. PMID:1861163. |
these results suggest that although hypoxia induces an increase in the extracellular dopamine levels (hence, an apparent increase in the activity of the dopaminergic neurons), this increase is not the result of an increase in dopamine release itself, but rather the result of inhibition of the dopamine reuptake mechanism. |
1991-09-04 |
2023-08-11 |
rat |
| T Galli, G Godeheu, F Artaud, J M Desce, A Pittaluga, L Barbeito, J Glowsinki, A Chéram. Specific role of N-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat. Neuroscience. vol 42. issue 1. 1991-08-30. PMID:1861773. |
specific role of n-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat. |
1991-08-30 |
2023-08-11 |
cat |
| T Galli, G Godeheu, F Artaud, J M Desce, A Pittaluga, L Barbeito, J Glowsinki, A Chéram. Specific role of N-acetyl-aspartyl-glutamate in the in vivo regulation of dopamine release from dendrites and nerve terminals of nigrostriatal dopaminergic neurons in the cat. Neuroscience. vol 42. issue 1. 1991-08-30. PMID:1861773. |
n-acetyl-aspartyl-glutamate interacted with dopaminergic neurons not only presynaptically in the caudate nucleus but also in the substantia nigra since a marked increase in [3h]dopamine release was observed both from local dendrites and from nerve terminals in the ipsilateral caudate nucleus when n-acetyl-aspartyl-glutamate (10(-7) m) was infused locally into the substantia nigra pars compacta. |
1991-08-30 |
2023-08-11 |
cat |
| L A Kukstas, C Domec, L Bascles, J Bonnet, D Verrier, J M Israel, J D Vincen. Different expression of the two dopaminergic D2 receptors, D2415 and D2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. Endocrinology. vol 129. issue 2. 1991-08-28. PMID:1830267. |
different expression of the two dopaminergic d2 receptors, d2415 and d2444, in two types of lactotroph each characterised by their response to dopamine, and modification of expression by sex steroids. |
1991-08-28 |
2023-08-11 |
rat |
| W J Smeet. Comparative aspects of the distribution of substance P and dopamine immunoreactivity in the substantia nigra of amniotes. Brain, behavior and evolution. vol 37. issue 3. 1991-08-22. PMID:1712657. |
in the present account, the relation between the descending, substance p (sp)-containing projection fibers from the striatum and the dopaminergic cell bodies in the midbrain tegmentum was investigated in several species of reptiles and the domestic chicken by means of antisera against sp and dopamine. |
1991-08-22 |
2023-08-11 |
chicken |
| M Hadjiconstantinou, J G Fitkin, A Dalia, N H Nef. Epidermal growth factor enhances striatal dopaminergic parameters in the 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-treated mouse. Journal of neurochemistry. vol 57. issue 2. 1991-08-21. PMID:1677029. |
intracerebroventricular infusion of epidermal growth factor (egf) into mice with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (mptp)-induced degeneration of dopaminergic nigrostriatal neurons partially enhanced the content of dopamine (da) and 3,4-dihydroxyphenylacetic acid as well as the activity of tyrosine hydroxylase in the striatum. |
1991-08-21 |
2023-08-11 |
mouse |